Paradigm Biocapital Advisors LP
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 1855655
NEW YORK, NY
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$415,053,936
+$183,055,239 QoQ
Shares Held
10,215,455
+38.7% QoQ
Ownership
9.41%
of shares outstanding
% of Portfolio
9.01%
of 13F equity value
Holder Rank
#2
of 223 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Derivatives in EWTX
reported options exposure · as of Mar 31, 2025CallValue
$11,000,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Paradigm Biocapital Advisors LP holds $4,608,890,546 across 28 Biotechnology names. EWTX ranks #2 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
6,361,323 | $1,191,348,571 | |
| 2 | EWTX |
Edgewise Therapeutics, Inc.
This page
|
10,215,455 | $415,053,936 | |
| 3 | GMAB |
Genmab A/S
|
13,133,131 | $360,767,108 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
3,840,778 | $340,984,270 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
1,576,385 | $209,233,581 | |
| 6 | ORKA |
Oruka Therapeutics, Inc.
|
2,144,526 | $204,094,539 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
6,357,523 | $198,736,168 | |
| 8 | BLTE |
Belite Bio, Inc
|
1,232,877 | $189,844,564 |
All Filings in EWTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $415,053,936 | 10,215,455 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $415,053,936 | 10,215,455 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $231,998,697 | 7,365,038 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $162,320,126 | 6,541,210 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $162,320,126 | 6,541,210 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $100,079,524 | 6,170,131 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $80,526,129 | 6,142,344 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,000,000 | 500,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $96,680,232 | 4,394,556 | Shares | Sole | 2025-05-15 | |
| 2025-01-27 | $131,979,172 | 4,738,929 | Shares | Sole | 2025-02-03 | |
| 2024-12-31 | $119,987,904 | 4,493,929 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $74,443,000 | 2,789,172 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,881,336 | 2,325,449 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,621,843 | 2,446,373 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||